Printer Friendly
The Free Library
19,604,530 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

BIOTRONIK Announces First Investigational Implant of the Tachos DR ICD with Atrial Therapy.


Business Editors

LAKE OSWEGO, Ore.--(BUSINESS WIRE)--Dec. 22, 2000

Biotronik, Inc. announced today the first investigational implant of the Tachos DR ICD ICD International Classification of Diseases (of the World Health Organization); intrauterine contraceptive device.

ICD
abbr.
 with Atrial Therapy.

This device represents a significant milestone in the treatment of arrhythmias in both the atrium and ventricle ventricle /ven·tri·cle/ (ven´tri-k'l) a small cavity or chamber, as in the brain or heart.ventric´ular

ventricle of Arantius  the rhomboid fossa, especially its lower end.
. The Tachos DR ICD with Atrial Therapy is the first device implanted in the US with the ability to treat both atrial and ventricular arrhythmias while providing rate-adaptive pacing therapy for the patient. Dr. Larry Gering performed the implantation at Owensboro Mercy Hospital in a patient with a history of paroxysmal paroxysmal (per´ksiz´ml),
adj recurring in paroxysms.
 atrial fibrillation and ventricular tachyarrhythmias. Biotronik, Inc. is sponsoring this Phase I IDE in 15 US centers to collect the necessary data to support the eventual PMA PMA (papillary-marginal-attached),
n a system of epidemiologic scoring of periodontal disease devised by Schour and Massler in which the symbols denote the areas involved in gingival inflammation.

PMA Progressive muscular atrophy
 approval of this device.

The Tachos DR ICD with Atrial Therapy features SMART Detection(TM), a clinically proven algorithm for the discrimination of ventricular and supraventricular tachycardias. Designed to increase specificity while maintaining sensitivity, SMART Detection demonstrated 94% specificity while maintaining 100% sensitivity in clinical trials of the Phylax AV. The ability to properly discriminate the origin of arrhythmias is crucial for appropriate treatment of the arrhythmia arrhythmia (ārĭth`mēə), disturbance in the rate or rhythm of the heartbeat. Various arrhythmias can be symptoms of serious heart disorders; however, they are usually of no medical significance except in the presence of . This device provides multiple detection and therapy options for the detection and treatment of both atrial and ventricular arrhythmias. The device is able to provide both pacing and shock therapies for the treatment of atrial or ventricular arrhythmias.

The Tachos DR with Atrial Therapy provides an extensive array of diagnostic capabilities to include 32 minutes of high fidelity, dual-chamber heart rhythm recordings (IEGMs). Other competitive features include SMART Success IEGM storage, Mode Conversion with programmable ventricular rate support, a PMT See photomultiplier tube.  termination algorithm, Real-time IEGMs to facilitate troubleshooting and programming, along with a sophisticated EP Test Mode to evaluate defibrillation Defibrillation Definition

Defibrillation is a process in which an electronic device sends an electric shock to the heart to stop an extremely rapid, irregular heartbeat, and restore the normal heart rhythm.
 therapy thresholds and the efficacy of anti-arrhythmic drug therapy in both chambers.

The implantation of the Tachos DR ICD with Atrial Therapy provides a unique solution to those patients who have, or may develop, atrial arrhythmias along with their ventricular arrhythmias. This device continues Biotronik's commitment to providing biomedical products that meet the clinical needs of physicians and patients.

BIOTRONIK, a world leader in the cardiovascular device industry, is committed to researching and developing new biomedical products. The company's North American headquarters is located in Lake Oswego, Oregon Lake Oswego (IPA: ɔs wiː ɡo) is a city in Clackamas County, Oregon, United States. (Small parts of the city extend into Multnomah County to the north and Washington County to the west. , with worldwide headquarters in Berlin, Germany.
COPYRIGHT 2000 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2000, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Dec 22, 2000
Words:381
Previous Article:Elantec Semiconductor Introduces Its Newest High-performance Laser Driver; The EL6249C Offers an Upgrade Path to Higher Speed CD-R/W Drives.
Next Article:Syscan Announces New Board of Directors.



Related Articles
BIOTRONIK Announces the First Implantation of the Tachos DR Implantable Cardioverter Defibrillator.
BIOTRONIK Receives Approval of the Belos VR Implantable Defibrillator.
BIOTRONIK Announces the First Implantation of a Single Lead Implantable Cardioverter Defibrillator with Dual-Chamber Discrimination.
BIOTRONIK Announces FDA Approval of the Tachos DR-Atrial Tx Implantable Cardioverter Defibrillator.
BIOTRONIK Announces First U.S. Market Implantation of the New Tachos DR-Atrial Tx Implantable Cardioverter Defibrillator.
BIOTRONIK's Innovative Belos Dual-Chamber ICD with Exclusive Wireless Remote Monitoring Receives FDA Approval.
BIOTRONIK Announces FDA Approval of the Tachos ATx ICD with Atrial Therapies.
BIOTRONIK Announces the First Implantation of Implantable Cardioverter Defibrillator with Cardiac Resynchronization and Atrial Tachyarrhythmia...
BIOTRONIK Announces First U.S. Implantation of a Biventricular Pacemaker for the AVAIL CLS/CRT Clinical Study.
Increased risk of paroxysmal atrial fibrillation episodes associated with acute increases in ambient air pollution.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles